Suppr超能文献

Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients.

作者信息

Alliot Carol

出版信息

J Clin Oncol. 2005 Jun 20;23(18):4237-8; author reply 4238-9. doi: 10.1200/JCO.2004.01.0207.

Abstract
摘要

相似文献

1
Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients.
J Clin Oncol. 2005 Jun 20;23(18):4237-8; author reply 4238-9. doi: 10.1200/JCO.2004.01.0207.
6
Systemic (adjuvant) treatment of primary breast cancer.
J Assoc Physicians India. 2001 Apr;49:451-3.
7
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27.
8
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Breast Cancer Res Treat. 2010 Oct;123(3):795-804. doi: 10.1007/s10549-010-1063-0. Epub 2010 Aug 3.
9
The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
J Clin Oncol. 2005 Sep 20;23(27):6807-9. doi: 10.1200/JCO.2005.02.3952.
10
Optimal chemotherapy for high-risk early-stage breast cancer.
J Clin Oncol. 2010 Jun 1;28(16):e263; author reply e264. doi: 10.1200/JCO.2010.28.1196. Epub 2010 Apr 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验